Mediolanum International Funds Ltd Has $7.09 Million Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Mediolanum International Funds Ltd trimmed its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 27.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,762 shares of the company's stock after selling 7,958 shares during the period. Mediolanum International Funds Ltd's holdings in Molina Healthcare were worth $7,086,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Innealta Capital LLC acquired a new position in Molina Healthcare in the 2nd quarter worth approximately $36,000. Ashton Thomas Private Wealth LLC bought a new position in Molina Healthcare during the second quarter valued at approximately $40,000. AM Squared Ltd acquired a new position in shares of Molina Healthcare during the 2nd quarter worth $59,000. UMB Bank n.a. boosted its holdings in Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company's stock worth $71,000 after purchasing an additional 101 shares in the last quarter. Finally, Fidelis Capital Partners LLC acquired a new position in Molina Healthcare during the first quarter worth $151,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Trading Up 0.6 %

Shares of MOH traded up $1.95 on Friday, reaching $325.54. 1,579,538 shares of the company's stock were exchanged, compared to its average volume of 525,746. The business has a 50 day moving average price of $335.23 and a two-hundred day moving average price of $329.72. Molina Healthcare, Inc. has a 12 month low of $272.69 and a 12 month high of $423.92. The stock has a market capitalization of $19.08 billion, a P/E ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.05. The company had revenue of $10.34 billion for the quarter, compared to analysts' expectations of $9.92 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business's quarterly revenue was up 21.0% compared to the same quarter last year. During the same period last year, the firm posted $5.05 earnings per share. Research analysts anticipate that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares of the company's stock, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the company's stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

MOH has been the topic of a number of analyst reports. StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, October 18th. Robert W. Baird reduced their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a research note on Thursday. TD Cowen lowered their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a "buy" rating on the stock in a research note on Wednesday, July 24th. Barclays boosted their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an "equal weight" rating in a research report on Friday. Finally, Stephens reaffirmed an "equal weight" rating and issued a $320.00 price target on shares of Molina Healthcare in a research report on Thursday, July 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $367.00.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.